USA - NASDAQ:TLSI - US89680M1018 - Common Stock
ChartMill assigns a Buy % Consensus number of 83% to TLSI. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-03-28 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-02-13 | Lake Street | Initiate | Buy |
| 2025-01-24 | Roth MKM | Reiterate | Buy -> Buy |
| 2024-12-17 | Cantor Fitzgerald | Initiate | Overweight |
| 2024-11-15 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-11-11 | Roth MKM | Initiate | Buy |
| 2024-10-25 | Northland Capital Markets | Initiate | Outperform |
| 2024-09-16 | Oppenheimer | Initiate | Outperform |
| 2024-06-27 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-05-30 | Canaccord Genuity | Initiate | Buy |
| 2024-05-10 | JonesTrading | Initiate | Buy |
13 analysts have analysed TLSI and the average price target is 11.82 USD. This implies a price increase of 169.13% is expected in the next year compared to the current price of 4.39.
The consensus rating for TRISALUS LIFE SCIENCES INC (TLSI) is 83.0769 / 100 . This indicates that analysts generally have a positive outlook on the stock.